Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A concise primer comparing decentralization aspects of PoW and PoS, outlining key tradeoffs that impact security and resilience.
27,693 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Global markets reel after a Supreme Court ruling narrows the Trump-era tariff framework, prompting emergency meetings...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
Quantum hype is everywhere, but one cloud leader is turning theory into revenue today. This article explains how they...
Investor-focused guide to perimeter solutions earnings. Learn how revenue, margins, and cash flow shape PRM stock pro...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Viemed's 2025 earnings outlook hinges on growing demand for home respiratory care, reimbursement dynamics, and cost c...
A federal judge dismissed the Binance terrorism lawsuit, citing lack of direct links to specific attacks. The ruling ...
Howard Hanna NYC appoints Hal Gavzie as executive director of business development, signaling a bold push to expand i...
Netflix moves to acquire Ben Affleck's AI startup for up to $600 million, signaling a rapid shift from internal tool-...
Could XRP slip below $2 by 2027? This guide breaks down the three big hurdles, explains why a lower price is plausibl...
mrbeast’s finance kids backed by Evolve Bank & Trust are under fresh regulatory scrutiny after the collapse of the f...